Medical Readiness: Safety and Efficacy of the Anthrax Vaccine

Pursuant to a congressional request, GAO discussed the results of its ongoing examination of the safety and efficacy of the anthrax vaccine, focusing on: (1) the short- and long-term safety of the vaccine; (2) the efficacy of the vaccine; and (3) problems the Food and Drug Administration (FDA) found in the vaccine production facility in Michigan that could compromise the safety, efficacy, and quality of the vaccine.